Lori Taylor
SVP Annexon Biosciences
Seminars
Wednesday 3rd December 2025
Optimizing Clinical Outcomes Utilizing Complement Mediators in Ophthalmic Indications: Are All Complement Pathways Equal?
1:30 pm
- Assess potential distinct roles for the Classical and Alternative Pathways in Age-Related Macular Degeneration (AMD)
- Describe the clinical outcomes with distinct complement approaches (Factor B, C3, C5, C1q)
- Debate the role of local versus systemic complement in AMD
